Latest Advances

  • Condition: Necrotizing Autoimmune Myopathy with Positive anti-Signal Recognition Particle and MDA-5 Autoantibodies
  • Journal: BMC cardiovascular disorders
  • Treatment Used: Immunotherapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with necrotizing autoimmune myopathy that was positive for anti-signal recognition particle and MDA-5 autoantibodies.
  • Condition: Dilated Cardiomyopathy
  • Journal: BioMed research international
  • Treatment Used: L-Carnitine
  • Number of Patients: 1455
  • Published —
This study tested the safety and efficacy of using L-carnitine to treat patients with dilated cardiomyopathy.
  • Condition: Nonischemic Dilated Cardiomyopathy
  • Journal: Mayo Clinic proceedings
  • Treatment Used: Cell Therapy
  • Number of Patients: 133
  • Published —
This study tested the safety and efficacy of using cell therapy to treat patients with nonischemic dilated cardiomyopathy.
  • Condition: Heart Failure (HF) Due to Dilated Cardiomyopathy in "-Super-Responder" with Return of a Reduced Left Ventricular (LV) Ejection Fraction to Normal
  • Journal: The American journal of case reports
  • Treatment Used: Discontinuation of Cardiac Resynchronization Therapy (CRT)
  • Number of Patients: 1
  • Published —
This case report describes the discontinuation of cardiac resynchronization therapy (CRT) for heart failure (HF) due to Dilated Cardiomyopathy in a 61-year-old female "-super-responder" with a return of a reduced left ventricular (LV) ejection fraction to normal.
  • Condition: Duchenne Muscular Dystrophy Patients with Left Ventricular Dysfunction
  • Journal: European review for medical and pharmacological sciences
  • Treatment Used: Sacubitril-Valsartan
  • Number of Patients: 3
  • Published —
The purpose of the study was to assess whether treatment with sacubitril/valsartan is well tolerated and may have beneficial effects in Duchenne Muscular Dystrophy patients with left ventricle dysfunction.
  • Condition: Dystrophic Epidermolysis Bullosa with Pleural Effusion and Dilated Cardiomyopathy
  • Journal: JPMA. The Journal of the Pakistan Medical Association
  • Treatment Used: Symptomatic Treatment
  • Number of Patients: 1
  • Published —
This case report describes a patient with dystrophic epidermolysis bullosa that developed pleural effusion and dilated cardiomyopathy.
  • Condition: Patient With Gitelman Syndrome (GS) and Dilated Cardiomyopath
  • Journal: World journal for pediatric & congenital heart surgery
  • Treatment Used: Orthotopic Heart Transplantation
  • Number of Patients: 1
  • Published —
This case report describes a child who was diagnosed with dilated cardiomyopathy and Gitelman syndrome (genetic electrolyte disorder; GS) treated with orthotopic heart transplantation.
  • Condition: COVID-19
  • Journal: Journal of clinical medicine
  • Treatment Used: Hydroxychloroquine
  • Number of Patients: 10668655
  • Published —
The study researched the safety of Hydroxychloroquine in patients with COVID-19.
  • Condition: Dilated Cardiomyopathy
  • Journal: The heart surgery forum
  • Treatment Used: Atorvastatin
  • Number of Patients: 401
  • Published —
This review of the literature examined the influence of atorvastatin on cardiac performance for patients with dilated cardiomyopathy.
  • Condition: Severe Heart Failure with Pulmonary Artery Thrombosis
  • Journal: Journal of cardiothoracic surgery
  • Treatment Used: Left Ventricular Assist Device (LVAD)
  • Number of Patients: 1
  • Published —
This case report describes a patient with severe heart failure and pulmonary artery thrombosis that was treated using a LVAD.
  • Condition: Dilated Cardiomyopathy
  • Journal: NULL
  • Treatment Used: Carvedilol
  • Number of Patients: 65
  • Published —
In this study, researchers evaluated the safety and effectiveness of a large dose of carvedilol for the survival of children with dilated cardiomyopathy.
  • Condition: Children with Dilated Cardiomyopathy
  • Journal: NULL
  • Treatment Used: Infant Jarvik 2015
  • Number of Patients: 3
  • Published —
This study reported the effect of continuous flow and intra-corporeal ventricular assist devices (CF VAD) in pediatric patients with cardiomyopathy (diseased heart muscle) refractory to pharmacological treatment.
Showing 1-12 of 36